Change history 19 November 2024 In the version of this article initially published online, earlier, incorrect versions of the Source data files were posted and are now replaced in the online version of the article
If you are currently taking a GLP-1, you know exactly what Im talking about
Preparing the patient for what to expect fosters realistic expectations, builds trust, and encourages adherence to therapy
For example, in one animal model, researchers found that a group of fatty acids known as short-chain fatty acids (SCFAs) significantly increase GLP-1 secretion
A section reserved for HealthVerity Marketplace data illustrates the richness of real-world evidence available to inform strategic decisions
3,7,8,9 This study is not a recommendation for a particular treatment but rather an observational analysis of available data for patients prescribed semaglutide